248 related articles for article (PubMed ID: 9927029)
1. Childhood hepatoblastomas frequently carry a mutated degradation targeting box of the beta-catenin gene.
Koch A; Denkhaus D; Albrecht S; Leuschner I; von Schweinitz D; Pietsch T
Cancer Res; 1999 Jan; 59(2):269-73. PubMed ID: 9927029
[TBL] [Abstract][Full Text] [Related]
2. Mutations and elevated transcriptional activity of conductin (AXIN2) in hepatoblastomas.
Koch A; Weber N; Waha A; Hartmann W; Denkhaus D; Behrens J; Birchmeier W; von Schweinitz D; Pietsch T
J Pathol; 2004 Dec; 204(5):546-54. PubMed ID: 15538750
[TBL] [Abstract][Full Text] [Related]
3. Beta-catenin accumulation and mutation of the CTNNB1 gene in hepatoblastoma.
Bläker H; Hofmann WJ; Rieker RJ; Penzel R; Graf M; Otto HF
Genes Chromosomes Cancer; 1999 Aug; 25(4):399-402. PubMed ID: 10398436
[TBL] [Abstract][Full Text] [Related]
4. Activation of beta-catenin in epithelial and mesenchymal hepatoblastomas.
Wei Y; Fabre M; Branchereau S; Gauthier F; Perilongo G; Buendia MA
Oncogene; 2000 Jan; 19(4):498-504. PubMed ID: 10698519
[TBL] [Abstract][Full Text] [Related]
5. Frequent deletions and mutations of the beta-catenin gene are associated with overexpression of cyclin D1 and fibronectin and poorly differentiated histology in childhood hepatoblastoma.
Takayasu H; Horie H; Hiyama E; Matsunaga T; Hayashi Y; Watanabe Y; Suita S; Kaneko M; Sasaki F; Hashizume K; Ozaki T; Furuuchi K; Tada M; Ohnuma N; Nakagawara A
Clin Cancer Res; 2001 Apr; 7(4):901-8. PubMed ID: 11309340
[TBL] [Abstract][Full Text] [Related]
6. Mutational spectrum of beta-catenin, AXIN1, and AXIN2 in hepatocellular carcinomas and hepatoblastomas.
Taniguchi K; Roberts LR; Aderca IN; Dong X; Qian C; Murphy LM; Nagorney DM; Burgart LJ; Roche PC; Smith DI; Ross JA; Liu W
Oncogene; 2002 Jul; 21(31):4863-71. PubMed ID: 12101426
[TBL] [Abstract][Full Text] [Related]
7. Frequent mutations in the beta-catenin gene in desmoid tumors from patients without familial adenomatous polyposis.
Miyoshi Y; Iwao K; Nawa G; Yoshikawa H; Ochi T; Nakamura Y
Oncol Res; 1998; 10(11-12):591-4. PubMed ID: 10367940
[TBL] [Abstract][Full Text] [Related]
8. Nuclear accumulation of beta-catenin without an additional somatic mutation in coding region of the APC gene in hepatoblastoma from a familial adenomatous polyposis patient.
Inukai T; Furuuchi K; Sugita K; Uno K; Ooi A; Sasaki F; Hamada J; Moriuchi T; Nakazawa S
Oncol Rep; 2004 Jan; 11(1):121-6. PubMed ID: 14654913
[TBL] [Abstract][Full Text] [Related]
9. A beta-catenin mutation in a sporadic colorectal tumor of the RER phenotype and absence of beta-catenin germline mutations in FAP patients.
Müller O; Nimmrich I; Finke U; Friedl W; Hoffmann I
Genes Chromosomes Cancer; 1998 May; 22(1):37-41. PubMed ID: 9591632
[TBL] [Abstract][Full Text] [Related]
10. No evidence for involvement of beta-catenin and APC in urothelial carcinomas.
Stoehr R; Krieg RC; Knuechel R; Hofstaedter F; Pilarsky C; Zaak D; Schmitt R; Hartmann A
Int J Oncol; 2002 May; 20(5):905-11. PubMed ID: 11956582
[TBL] [Abstract][Full Text] [Related]
11. Analysis of somatic APC mutations in rare extracolonic tumors of patients with familial adenomatous polyposis coli.
Bläker H; Sutter C; Kadmon M; Otto HF; Von Knebel-Doeberitz M; Gebert J; Helmke BM
Genes Chromosomes Cancer; 2004 Oct; 41(2):93-8. PubMed ID: 15287021
[TBL] [Abstract][Full Text] [Related]
12. Beta-catenin mutations and protein accumulation in all hepatoblastomas examined from B6C3F1 mice treated with anthraquinone or oxazepam.
Anna CH; Sills RC; Foley JF; Stockton PS; Ton TV; Devereux TR
Cancer Res; 2000 Jun; 60(11):2864-8. PubMed ID: 10850429
[TBL] [Abstract][Full Text] [Related]
13. Sporadic fundic gland polyposis: a clinical, histological, and molecular analysis.
Torbenson M; Lee JH; Cruz-Correa M; Ravich W; Rastgar K; Abraham SC; Wu TT
Mod Pathol; 2002 Jul; 15(7):718-23. PubMed ID: 12118109
[TBL] [Abstract][Full Text] [Related]
14. Cribriform-morular variant of papillary thyroid carcinoma: a pathological and molecular genetic study with evidence of frequent somatic mutations in exon 3 of the beta-catenin gene.
Xu B; Yoshimoto K; Miyauchi A; Kuma S; Mizusawa N; Hirokawa M; Sano T
J Pathol; 2003 Jan; 199(1):58-67. PubMed ID: 12474227
[TBL] [Abstract][Full Text] [Related]
15. Beta-catenin mutations in sporadic fundic gland polyps.
Sekine S; Shibata T; Yamauchi Y; Nakanishi Y; Shimoda T; Sakamoto M; Hirohashi S
Virchows Arch; 2002 Apr; 440(4):381-6. PubMed ID: 11956818
[TBL] [Abstract][Full Text] [Related]
16. Somatic mutations of the APC gene in sporadic hepatoblastomas.
Oda H; Imai Y; Nakatsuru Y; Hata J; Ishikawa T
Cancer Res; 1996 Jul; 56(14):3320-3. PubMed ID: 8764128
[TBL] [Abstract][Full Text] [Related]
17. Predominance of beta-catenin mutations and beta-catenin dysregulation in sporadic aggressive fibromatosis (desmoid tumor).
Tejpar S; Nollet F; Li C; Wunder JS; Michils G; dal Cin P; Van Cutsem E; Bapat B; van Roy F; Cassiman JJ; Alman BA
Oncogene; 1999 Nov; 18(47):6615-20. PubMed ID: 10597266
[TBL] [Abstract][Full Text] [Related]
18. Somatic mutations of beta-catenin play a crucial role in the tumorigenesis of sporadic hepatoblastoma.
Jeng YM; Wu MZ; Mao TL; Chang MH; Hsu HC
Cancer Lett; 2000 Apr; 152(1):45-51. PubMed ID: 10754205
[TBL] [Abstract][Full Text] [Related]
19. Common mutations of beta-catenin in adamantinomatous craniopharyngiomas but not in other tumours originating from the sellar region.
Buslei R; Nolde M; Hofmann B; Meissner S; Eyupoglu IY; Siebzehnrübl F; Hahnen E; Kreutzer J; Fahlbusch R
Acta Neuropathol; 2005 Jun; 109(6):589-97. PubMed ID: 15891929
[TBL] [Abstract][Full Text] [Related]
20. Diverse mechanisms of beta-catenin deregulation in ovarian endometrioid adenocarcinomas.
Wu R; Zhai Y; Fearon ER; Cho KR
Cancer Res; 2001 Nov; 61(22):8247-55. PubMed ID: 11719457
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]